Evaluation of Easym, a Clonotypic Mass Spectrometry Assay, and Euroflow Minimal Residual Disease Assessment in Multiple Myeloma

被引：0
|
作者：
Zhao, Jessie [1 ,2 ]
Khong, Tiffany T. [1 ,2 ]
Gorniak, Malgorzata [3 ]
Khaled, Abir [4 ]
McDonald, Zac [4 ]
Reynolds, John [1 ,2 ]
Wong, Daniel [1 ,2 ]
Bingham, Nicholas [1 ,2 ]
Johnston, Anna M. [5 ]
Motorna, Olga [6 ]
Murphy, Nicholas E. [5 ]
Quach, Hang [7 ]
Yang, Liqiang [4 ]
Spencer, Andrew [1 ,2 ]
机构：
[1] Alfred Hosp, Dept Malignant Haematol & Stem Cell Transplantat, Melbourne, Vic, Australia
[2] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic, Australia
[3] Alfred Hosp, Alfred Pathol, Melbourne, Vic, Australia
[4] Rapid Novor, Kitchener, ON, Canada
[5] Royal Hobart Hosp, Hobart, Tas, Australia
[6] Eastern Hlth, Melbourne, Vic, Australia
[7] St Vincents Hosp Melbourne, East Melbourne, Australia
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-179742
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Minimal residual disease in multiple myeloma
    Moukalled, Nour
    Malard, Florent
    Bazarbachi, Ali
    Mohty, Mohamad
    PRESSE MEDICALE, 2025, 54 (01):
  • [32] Clonotypic Features of Rearranged Immunoglobulin Genes Yield Personalized Biomarkers for Minimal Residual Disease Monitoring in Multiple Myeloma
    Langerhorst, Pieter
    Brinkman, Arie B.
    VanDuijn, Martijn M.
    Wessels, Hans J. C. T.
    Groenen, Patricia J. T. A.
    Joosten, Irma
    van Gool, Alain J.
    Gloerich, Jolein
    Scheijen, Blanca
    Jacobs, Joannes F. M.
    CLINICAL CHEMISTRY, 2021, 67 (06) : 867 - 875
  • [33] Prognostic value of minimal residual disease response assessment in multiple myeloma
    Takamatsu, Hiroyuki
    ANNALS OF ONCOLOGY, 2015, 26 : 25 - 25
  • [34] Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients
    Maiolino, Angelo
    Da Costa, Elaine Sobral
    Orfao, Alberto
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [35] Clinical relevance of Minimal residual Disease assessment by NGS in Multiple Myeloma
    Martinez-Lopez, Joaquin
    Wong, Sandy
    Shah, Nina
    Bahri, Natasha
    Zhou, Kali
    Martin, Thomas
    Wolf, Jeffrey
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E179 - E180
  • [36] Post-transplant minimal residual disease assessment in Multiple myeloma
    Mookerjee, Anjali
    Dahiya, Meetu
    Gupta, Ritu
    Kumar, Rakesh
    Sharma, Atul
    Luthra, Kalpana
    Sharma, Alpana
    Kaur, Gurvinder
    Saxena, Renu
    Pandey, Ravindra Mohan
    Sharma, Om Dutt
    Sahoo, Ranjit
    Kumar, Lalit
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E180 - E180
  • [37] Evaluation of Molecular Minimal Residual Disease in Multiple Myeloma: An Institutional Experience
    Hanley, Tim
    Clement, Parker
    Dickey, Laura
    Li, K. David
    MODERN PATHOLOGY, 2018, 31 : 519 - 520
  • [38] Evaluation of Molecular Minimal Residual Disease in Multiple Myeloma: An Institutional Experience
    Hanley, Tim
    Clement, Parker
    Dickey, Laura
    Li, K. David
    LABORATORY INVESTIGATION, 2018, 98 : 519 - 520
  • [39] Role of Imaging in the Evaluation of Minimal Residual Disease in Multiple Myeloma Patients
    Zamagni, Elena
    Tacchetti, Paola
    Barbato, Simona
    Cavo, Michele
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 9
  • [40] Clonotypic Light Chain Peptides Identified for Monitoring Minimal Residual Disease in Multiple Myeloma without Bone Marrow Aspiration
    Bergen, H. Robert, III
    Dasari, Surendra
    Dispenzieri, Angela
    Mills, John R.
    Ramirez-Alvarado, Marina
    Tschumper, Renee C.
    Jelinek, Diane F.
    Barnidge, David R.
    Murray, David L.
    CLINICAL CHEMISTRY, 2016, 62 (01) : 243 - 251
12345